F632-0146 Screening compound: N~2~-(4-methylcyclohexyl)-1-[(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)sulfonyl]-2-pyrrolidinecarboxamide

F632-0146 Screening compound: N~2~-(4-methylcyclohexyl)-1-[(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)sulfonyl]-2-pyrrolidinecarboxamide
F632-0146 Screening compound: N~2~-(4-methylcyclohexyl)-1-[(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)sulfonyl]-2-pyrrolidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F632-0146
N~2~-(4-methylcyclohexyl)-1-[(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)sulfonyl]-2-pyrrolidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F632-0146

Molecular Formula

C21H29N3O5S (C21 H29 N3 O5 S)

Compound Name

N~2~-(4-methylcyclohexyl)-1-[(6-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)sulfonyl]-2-pyrrolidinecarboxamide

IUPAC name

n/a

SMILES

CC(CC1)CCC1NC(C(CCC1)N1S(c(cc1OC2)c(C)cc1NC2=O)(=O)=O)=O

InChI

InChI=1S/C21H29N3O5S/c1-13-5-7-15(8-6-13)22-21(26)17-4-3-9-24(17)30(27,28)19-11-18-16(10-14(19)2)23-20(25)12-29-18/h10-11,13,15,17H,3-9,12H2,1-2H3,(H,22,26)(H,23,25)/t13?,15?,17-/m0/s1

InChI Key

UEMWMGVMEOZIQU-PGEKIEPBSA-N

MDL Number (MFCD)

MFCD27180390

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.54

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.612

Distribution Coefficient, logD

2.611

Water Solubility, LogSw

-3.01

Polar Surface Area

90.195

Acid Dissociation Constant (pKa)

10.30

Base Dissociation Constant (pKb)

-0.36

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.90

F632-0146 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Neuropeptide S Library (2850 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with F632-0146 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F632-0146?
Check Price and Availability of F632-0146, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F632-0146 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F632-0146
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F632-0146
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F632-0146 available by request